Previous studies have shown that artesunate exposure induces apoptosis in cancer cells [10,15,17,35,36,37]; therefore, we aimed to determine if inhibiting antiapoptotic Bcl-2 family proteins could enhance artesunate efficacy in ovarian cancer cells. This evidence concerns the gene BCL2 and ovarian carcinoma.